<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M534</article-id>
      <article-id pub-id-type="publisher-id">molbank-2007-M534</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis of 4-Amino-1,7,8,9-tetramethyl-4-aza-tricyclo[5.2.1.0<sup>2,6</sup>]dec-8-ene-3,5-dione</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Struga</surname>
            <given-names>Marta</given-names>
          </name>
          <xref rid="c1-molbank-2007-M534" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kossakowski</surname>
            <given-names>Jerzy</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2007-M534">The Medical University, Department of Medical Chemistry, 3 Oczki Str., 02-007 Warsaw, Poland; Tel/Fax: (+4822)-628-06-79</aff>
      <author-notes>
        <corresp id="c1-molbank-2007-M534"><label>*</label>Author to whom correspondence should be addressed. E-Mail: <email>strugam@wp.pl</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <volume>2007</volume>
      <issue>2</issue>
      <elocation-id>M534</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>09</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>01</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2007 by MDPI (http://www.mdpi.org/).</copyright-statement>
        <copyright-year>2007</copyright-year>
        <license>
          <p>Reproduction is permitted for noncommercial purposes.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>1,7,8,9-Tetramethyl-4-oxa-tricyclo[5.2.1.0<sup>2,6</sup>]dec-8-ene-3,5-dione</kwd>
        <kwd>4-Amino-1,7,8,9-tetramethyl-4-aza-tricyclo[5.2.1.0<sup>2,6</sup>]dec-8-ene-3,5-dione</kwd>
        <kwd>hydrazine hydrate</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Various imide derivatives of 1,7,8,9-tetramethyl-4-aza-tricyclo[5.2.1.0<sup>2,6</sup>]dec-8-ene-3,5-dione (2) have been reported and shown to exhibit an anxiolytic activities [<xref ref-type="bibr" rid="B1-molbank-2007-M534">1</xref>].</p>
      <p>Starting materials e.g. 1,2,3,4-tetramethyl-1,3-cyclopentadiene, and furan-2,5-dione were commercially available reagents.
	  <disp-formula>
        <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M534-i001.tif"/>
        </disp-formula></p>
      <p><italic>1,7,8,9-Tetramethyl-4-oxa-tricyclo[5.2.1.0<sup>2,6</sup>]dec-8-ene-3,5-dione</italic> (1).</p>
      <p>The synthesis of (1) was performed from 1,2,3,4-tetramethyl-1,3-cyclopentadiene and furan-2,5-dione according to the method described previously [<xref ref-type="bibr" rid="B2-molbank-2007-M534">2</xref>]. (Lit. m.p. 108-109<sup>0</sup>C. Yield 68 %.)</p>
      <p>White crystals, yield 76 %.</p>
      <p>Melting point: 110&#xB0;C.</p>
      <p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x3B4; (ppm): 3.35 (s, 2H, CH-C=O); 3.29 (s, 12H, CH<sub>3</sub>); 2.72 (s, 2H, CH<sub>2</sub>).</p>
      <p><sup>13</sup>C-NMR (100 MHz, CDCl<sub>3</sub>) &#x3B4; (ppm):  171.3, 138.4, 137.6, 63.9, 56.3, 54.4, 16.6, 11.0.</p>
      <p>ESI MS: m/z = 243.3 [M + Na]<sup>+</sup> (100%).</p>
      <p>Elemental Analysis: Calculated for C13H16O3 (220.26): C, 70.89 %; H, 7.32 %. Found: C, 70.92 %; H, 7.23 %.</p>
      <p><italic>4-Amino-1,7,8,9-tetramethyl-4-aza-tricyclo[5.2.1.0<sup>2,6</sup>]dec-8-ene-3,5-dione</italic> (2).</p>
      <p>A mixture of anhydride 1 (0.01 mole) and hydrazine hydrate (80% water solution) (10 ml) was refluxed for 5 h. The solvents were evaporated. The residue was purified by a column chromatography (silica gel, chloroform/methanol 19:1) to give compound 2.</p>
      <p>White crystals, yield 89 %.</p>
      <p>Melting point: 161&#xB0;C.</p>
      <p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x3B4; (ppm): 4.52 (s, 2H, NH<sub>2</sub>); 3.02 (s, 2H, CH-C=O); 1.53 (s, 6H, CH<sub>3</sub>); 1.47 (s, 6H, CH<sub>3</sub>); 1.33 (dd, 2H, CH<sub>2</sub>).</p>
      <p><sup>13</sup>C-NMR (100 MHz, CDCl<sub>3</sub>) &#x3B4; (ppm):  174.4, 137.6, 63.6, 55.2, 51.9, 17.1, 10.9.</p>
      <p>ESI MS: m/z = 257.2 [M + Na]<sup>+</sup> (100%).</p>
      <p>Elemental Analysis: Calculated for C13H18O2N2(234.3): C, 66.07 %; H, 8.53 %; N, 11.85 %. Found: C, 66.32 %; H, 8.32 %; N, 11.89 %.</p>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2007-M534">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2007-M534-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M534-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2007-M534-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M534-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2007-M534-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M534-s002-mod.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
<supplementary-material id="molbank-2007-M534-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M534-s002.mol">
   <label>Supplementary File 4</label>
</supplementary-material>
    </app>
</app-group>
  <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2007-M534">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kossakowski</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ku&#x15B;mierczyk</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Acta Pol. Pharm.</source>
          <year>1999</year>
          <volume>56</volume>
          <fpage>94</fpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2007-M534">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mironov</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Sobolev</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Elizarova</surname>
              <given-names>A.N.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron</source>
          <year>1963</year>
          <volume>19</volume>
          <fpage>1939</fpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
